Cargando…

Predictors of mortality in patients with COVID-19 by flow cytometry

Despite the great impact of severe acute respiratory syndrome caused by coronavirus 2 (SARS-CoV-2), we still lack techniques that allow us to anticipate the natural history of the disease in order to avoid or shorten the clinical period of the disease. The values of nine cytokines were measured in C...

Descripción completa

Detalles Bibliográficos
Autores principales: Izquierdo, Marco Bonilla, Romo, Ana María Navas, Zafra, Aurora Gema Sicilia, Garrido, Juan de Dios López-González
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918322/
https://www.ncbi.nlm.nih.gov/pubmed/38014400
http://dx.doi.org/10.1016/j.clicom.2023.02.003
_version_ 1784886584521261056
author Izquierdo, Marco Bonilla
Romo, Ana María Navas
Zafra, Aurora Gema Sicilia
Garrido, Juan de Dios López-González
author_facet Izquierdo, Marco Bonilla
Romo, Ana María Navas
Zafra, Aurora Gema Sicilia
Garrido, Juan de Dios López-González
author_sort Izquierdo, Marco Bonilla
collection PubMed
description Despite the great impact of severe acute respiratory syndrome caused by coronavirus 2 (SARS-CoV-2), we still lack techniques that allow us to anticipate the natural history of the disease in order to avoid or shorten the clinical period of the disease. The values of nine cytokines were measured in COVID-19+ patients admitted to the Hospital Universitario Reina Sofía (HURS) using flow cytometry. The cytokines measured are IL-1ß, IL-6, MCP-1, IP-10, IL-10, IL-8, IL-12, IFN-γ and TNF-α. Given the absence of previous studies on cytokine values in healthy patients using the flow cytometry technique, and the low availability of resources in the first waves of COVID-19, a control group was lacking, all resources were employed for monitoring sick patients. However, this study has revealed a greater increase in two specific cytokines, which are also found to be higher than the rest in healthy patients: MCP-1 and IP-10, which are mainly responsible for cytokine storm and post-disease thrombosis.
format Online
Article
Text
id pubmed-9918322
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Authors. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-99183222023-02-13 Predictors of mortality in patients with COVID-19 by flow cytometry Izquierdo, Marco Bonilla Romo, Ana María Navas Zafra, Aurora Gema Sicilia Garrido, Juan de Dios López-González Clinical Immunology Communications Article Despite the great impact of severe acute respiratory syndrome caused by coronavirus 2 (SARS-CoV-2), we still lack techniques that allow us to anticipate the natural history of the disease in order to avoid or shorten the clinical period of the disease. The values of nine cytokines were measured in COVID-19+ patients admitted to the Hospital Universitario Reina Sofía (HURS) using flow cytometry. The cytokines measured are IL-1ß, IL-6, MCP-1, IP-10, IL-10, IL-8, IL-12, IFN-γ and TNF-α. Given the absence of previous studies on cytokine values in healthy patients using the flow cytometry technique, and the low availability of resources in the first waves of COVID-19, a control group was lacking, all resources were employed for monitoring sick patients. However, this study has revealed a greater increase in two specific cytokines, which are also found to be higher than the rest in healthy patients: MCP-1 and IP-10, which are mainly responsible for cytokine storm and post-disease thrombosis. The Authors. Published by Elsevier Inc. 2023-12 2023-02-11 /pmc/articles/PMC9918322/ /pubmed/38014400 http://dx.doi.org/10.1016/j.clicom.2023.02.003 Text en © 2023 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Izquierdo, Marco Bonilla
Romo, Ana María Navas
Zafra, Aurora Gema Sicilia
Garrido, Juan de Dios López-González
Predictors of mortality in patients with COVID-19 by flow cytometry
title Predictors of mortality in patients with COVID-19 by flow cytometry
title_full Predictors of mortality in patients with COVID-19 by flow cytometry
title_fullStr Predictors of mortality in patients with COVID-19 by flow cytometry
title_full_unstemmed Predictors of mortality in patients with COVID-19 by flow cytometry
title_short Predictors of mortality in patients with COVID-19 by flow cytometry
title_sort predictors of mortality in patients with covid-19 by flow cytometry
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918322/
https://www.ncbi.nlm.nih.gov/pubmed/38014400
http://dx.doi.org/10.1016/j.clicom.2023.02.003
work_keys_str_mv AT izquierdomarcobonilla predictorsofmortalityinpatientswithcovid19byflowcytometry
AT romoanamarianavas predictorsofmortalityinpatientswithcovid19byflowcytometry
AT zafraauroragemasicilia predictorsofmortalityinpatientswithcovid19byflowcytometry
AT garridojuandedioslopezgonzalez predictorsofmortalityinpatientswithcovid19byflowcytometry